A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Main Author: | Shehab, Habibul Mohsin |
---|---|
Other Authors: | Yasmin, Hasina |
Format: | Thesis |
Language: | English |
Published: |
Brac University
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/10361/22683 |
Similar Items
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
by: Tabassum, Nadira
Published: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
by: Mahee, Sadique Abdal
Published: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
by: Alim, Abdul
Published: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
by: Karmaker, Swastika
Published: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
by: Jahan, Nusrat
Published: (2023)